Medicamen Biotech’s Bhiwadi Formulation facility completes EU GMP Inspection

31 May 2024 Evaluate

The Inspection Department, Division of Production & Distribution Control, National Organisation for Medicines, GREECE, has inspected the General Tablets and Liquid Orals Formulation facility of Medicamen Biotech located at Phase IV, Industrial Area, Bhiwadi from May 28, 2024 and concluded on May 30, 2024.

The inspection closed with some procedural observations which will be well responded within Stipulated time. However, the Final approval (EU GMP Certification) is expected after submission of formal response to Greece Authorities. 

Medicamen Biotech is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets.


Medicamen Biotech Share Price

381.90 -8.35 (-2.14%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×